Skip to content
Georgia Commons
Menu

Official Code of Georgia Annotated

Title 31. HEALTH · Chapter 11. EMERGENCY MEDICAL SERVICES · Article 3. PERSONNEL

31-11-55. Services which may be rendered by certified cardiac technicians and trainees.

Active

Current through: Including Acts of the 2025 Session of the General Assembly of Georgia.

  1. (a)

    Upon certification by the department, cardiac technicians may do any of the following:#

    1. (1)

      Render first-aid and resuscitation services;#

    2. (2)

      Upon the order of a duly licensed physician and as recommended by the Georgia Emergency Medical Services Advisory Council and approved by the department:#

      1. (A)

        Perform cardiopulmonary resuscitation and defibrillation in a hemodynamically unstable patient;#

      2. (B)

        Administer approved intravenous solutions;#

      3. (C)

        Administer parenteral injections of antiarrhythmic agents, vagolytic agents, chronotropic agents, alkalizing agents, analgesic agents, and vasopressor agents or administer opioid antagonists;#

      4. (D)

        Perform pulmonary ventilation by esophageal airway and endotracheal intubation; and#

      5. (E)

        Upon the order of a duly licensed physician during a public health emergency, as defined in Code Section 31-12-1.1, administer vaccines.#

  2. (b)

    While in training preparatory to becoming certified, cardiac technician trainees may perform any of the functions specified in this Code section under the direct supervision of a duly licensed physician or a registered nurse.#

The notes below are printed with the section but are not enacted law (O.C.G.A. § 1-1-1(c)). They are shown apart from the text.

History

Code 1933, § 88-3112.4, enacted by Ga. L. 1977, p. 281, § 5; Ga. L. 2001, p. 1145, § 5; Ga. L. 2014, p. 683, § 2-5/HB 965; Ga. L. 2021, p. 782, § 6/SB 46.

Editor's notes

Ga. L. 2014, p. 683, § 2-1/HB 965, not codified by the General Assembly, provides: “WHEREAS, Naloxone is an opioid antagonist developed to counter the effects of opiate overdose, specifically the life threatening depression of the central nervous and respiratory systems; and “WHEREAS, Naloxone is clinically administered via intramuscular, intravenous, or subcutaneous injection; and “WHEREAS, Naloxone is administered outside of a clinical setting or facility intranasally via nasal atomizer; and “WHEREAS, the American Medical Association supported the lay administration of this life saving drug in 2012; and “WHEREAS, similar Naloxone access laws have reversed more than 10,000 opioid overdoses by lay people in other states; and “WHEREAS, the American Medical Association acknowledged that ‘fatalities caused by opioid overdose can devastate families and communities, and we must do more to prevent these unnecessary deaths’; and “WHEREAS, the National Institutes of Health found that Naloxone ‘lacks any psychoactive or addictive qualities . . . without any potential for abuse . . . [and] medical side effects or other problematic unintended consequences associated with Naloxone have not been reported’; and “WHEREAS, any administration of Naloxone to an individual experiencing an opioid overdose must be followed by professional medical attention and treatment.” Ga. L. 2014, p. 683, § 3-1/HB 965, not codified by the General Assembly, provides, in part, that Parts I and II of this Act shall apply to all acts committed on or after April 24, 2014. For application of this statute in 2021, see Executive Order 01.07.21.02.

Read the official page (the state's PDF, opened at the page this text was read from).

Current through: Including Acts of the 2025 Session of the General Assembly of Georgia.

Text read from t31-(v23)-2025-pdf.pdf, Volume V23, 2025 edition, pages 717 to 718; merge action: bound only; file SHA-256 ba5a57f85d04.